Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1595888 NEW YORK, NY
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$37,910
-$117,590 QoQ
Shares Held
164,827
-39.6% QoQ
Ownership
0.371%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 48 holders
Holding Since
Jun 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Derivatives in VTGN

reported options exposure · as of Jun 30, 2026
CallValue
$17,595
CallShares
76,500
PutValue
$5,635
PutShares
24,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. VTGN ranks #256 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in VTGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,635 24,500
2026-06-30 $17,595 76,500
2026-06-30 $37,910 164,827
2026-03-31 $155,500 272,811
2026-03-31 $13,224 23,200
2025-12-31 $52,602 79,700
2025-12-31 $347,902 527,127
2025-09-30 $1,074,524 302,683
2025-09-30 $51,475 14,500
2025-06-30 $190,102 95,051
2024-09-30 $59,172 19,659
2023-12-31 $112,771 21,940
2022-09-30 $10,223 68,156
2022-03-31 $72,528 58,491
2021-06-30 $521,781 165,645
2021-03-31 $42,440 19,925
2020-06-30 $38,669 72,961